{"effective_time":"20151124","id":"44e4944f-3e81-5b60-e054-00144ff8d46c","instructions_for_use":["Testagen(R) TDS Testosterone 5% Instructions for use To be applied in accordance with enclosed instructions."],"openfda":{},"package_label_principal_display_panel":["Testagen TDS Testosterone 5% Principal Display panel - Clinical trial materials For Clinical Trial Use Only EudraCT No: 2013-001766-42 PARC-Testosterone-D-01/09/13 Subject number: S/R_____ For topical application To be applied in accordance with enclosed instructions Investigator: Prof R Langford Use by: 07 / 2017 Batch no: TDST-004 Keep out of the reach of and avoid contact with women & children Store at room temp. TLC Advanced Therapies Centre Pharm. Caution – New Drug – Limited by Law to Investigational Use See Image CDER Testagen Label Image of sample label"],"set_id":"44e4944f-3e80-5b60-e054-00144ff8d46c","spl_product_data_elements":["Testagen Testosterone (1,2,6,7-3H)TESTOSTERONE (1,2,6,7-3H)TESTOSTERONE"],"version":"4"}